Drug Search Results
More Filters [+]

Collagenase clostridium histolyticum

Alternative Names: collagenase clostridium histolyticum, Xiaflex, qwo
Latest Update: 2024-01-24
Latest Update Note: News Article

Product Description

Collagenase clostridium histolyticum injection is used to treat Dupuytren's contracture with a palpable cord. It is also used to treat Peyronie's disease with a palpable plaque and curvature deformity in men. (Sourced from: https://www.mayoclinic.org/drugs-supplements/collagenase-clostridium-histolyticum-injection-route/description/drg-20073911)

Mechanisms of Action: MMP Inhibitor

Novel Mechanism: No

Modality: Nondrug

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Brazil | Bulgaria | Canada | European Medicines Agency | Greece | Hungary | Ireland | Lithuania | Malaysia | Poland | Portugal | Slovakia | Slovenia | Sweden

Approved Indications: Contracture | Dupuytren Contracture | Cellulite

Known Adverse Events: Pain Unspecified | Contracture | Dupuytren Contracture | Edema | Erythema | Pruritus

Company: Endo
Company Location: DUBLIN 4 L2 00000
Company CEO: Blaise Coleman
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Collagenase clostridium histolyticum

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Cellulite|Edema

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

APHRODITE

P2

Completed

Edema|Cellulite

2023-01-03

24%

APHRODITE

P2

Completed

Edema|Cellulite

2023-01-03

24%

APHRODITE

P2

Completed

Edema|Cellulite

2023-01-03

24%

Recent News Events